Literature DB >> 30452981

RETRACTED: Long non-coding RNA LINC00978 promotes cell proliferation and tumorigenesis via regulating microRNA-497/NTRK3 axis in gastric cancer.

Ju-Yuan Bu1, Wei-Ze Lv2, Yi-Feng Liao3, Xiao-Yu Xiao4, Bao-Jun Lv5.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editors-in-Chief. Given the comments of Dr Elisabeth Bik regarding this article “…the Western blot bands in all 400+ papers are all very regularly spaced and have a smooth appearance in the shape of a dumbbell or tadpole, without any of the usual smudges or stains. All bands are placed on similar looking backgrounds, suggesting they were copy/pasted from other sources, or computer generated”, the journal requested the authors to provide the raw data. However, the authors were not able to fulfil this request and therefore the Editors-in-Chief decided to retract the article.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gastric cancer; LINC00978; microRNA-497

Mesh:

Substances:

Year:  2018        PMID: 30452981     DOI: 10.1016/j.ijbiomac.2018.11.162

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  9 in total

Review 1.  MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis.

Authors:  Chenming Zhong; Zijun Xie; Ling-Hui Zeng; Chunhui Yuan; Shiwei Duan
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

2.  Construction of a Prognostic Immune-Related LncRNA Risk Model for Gastric Cancer.

Authors:  Wei Ding; Pengcheng Sun; Yulin Tan; Huaji Jiang; Cheng Xi; Ling Zhuang; Yixin Xu; Xuezhong Xu
Journal:  J Oncol       Date:  2022-06-25       Impact factor: 4.501

Review 3.  Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders.

Authors:  Majid Ghasemian; Masoumeh Rajabibazl; Unes Sahebi; Samira Sadeghi; Reza Maleki; Veys Hashemnia; Reza Mirfakhraie
Journal:  Cancer Cell Int       Date:  2022-06-17       Impact factor: 6.429

4.  LncRNA00978 contributes to growth and metastasis of hepatocellular carcinoma cells via mediating microRNA-125b-5p/SOX12 pathway.

Authors:  Zhiqing Cheng; Limei Gong; Qinghe Cai
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

5.  Characterization of long non-coding RNA and messenger RNA profiles in laryngeal cancer by weighted gene co-expression network analysis.

Authors:  Huanhuan Liu; Yi Sun; Huan Tian; Xiaolian Xiao; Jiaqi Zhang; Yongzhen Wang; Fengyan Yu
Journal:  Aging (Albany NY)       Date:  2019-11-18       Impact factor: 5.682

6.  Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway.

Authors:  Shuwei Zhang; Chen Li; Junchao Liu; Fengxue Geng; Xiaoting Shi; Qian Li; Ze Lu; Yaping Pan
Journal:  FEBS J       Date:  2020-02-12       Impact factor: 5.542

7.  Genome-wide analysis identifies critical DNA methylations within NTRKs genes in colorectal cancer.

Authors:  Zijian Chen; Zenghong Huang; Yanxin Luo; Qi Zou; Liangliang Bai; Guannan Tang; Xiaolin Wang; Guangwen Cao; Meijin Huang; Jun Xiang; Huichuan Yu
Journal:  J Transl Med       Date:  2021-02-16       Impact factor: 5.531

8.  LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression.

Authors:  Xueying Xu; Jianmei Gu; Xiaoge Ding; Guohong Ge; Xueyan Zang; Runbi Ji; Meng Shao; Zheying Mao; Yu Zhang; Jiayin Zhang; Fei Mao; Hui Qian; Wenrong Xu; Hui Cai; Feng Wang; Xu Zhang
Journal:  Cell Death Dis       Date:  2019-10-03       Impact factor: 8.469

9.  LncRNA AWPPH as a prognostic predictor in human cancers in Chinese population: evidence from meta-analysis.

Authors:  Yongfeng Li; Xinmiao Rui; Daobao Chen; Haojun Xuan; Hongjian Yang; Xuli Meng
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.